U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07620392) titled 'An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis' on May 27.
Brief Summary: The study will evaluate the long-term safety and efficacy of Afimkibart (also known as RO7790121) in participants with moderate to severe Rheumatoid Arthritis (RA) who have an inadequate response or intolerance to tumor necrosis factor (TNF) and/or Janus kinase (JAK) inhibitors, and who were previously treated with Afimkibart.
Study Start Date: June 05
Study Type: INTERVENTIONAL
Condition:
Rheumatoid Arthritis
Intervention:
DRUG: Afimkibart
Participants will receive Afimkibart as per the...